Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared a post on X:
“What’s the future of muscle-invasive bladder cancer at SimposioSOGUG25
Pathological CR rates of 57% for EVP point towards cystectomy being delayed until maximum EVP effectiveness. Also, fewer patients will have cystectomy. Studies are needed to ensure this approach is safe.”
More posts featuring Tom Powles.
